Neutrophil Lymphocyte Ratio as a Predictor of Outcome in Critically Traumatic Patients

Neutrophil lymphocyte ratio NLR is an important index that evaluate the inflammatory status . It is a cost effective and readily available , and simply calculated , so that why investigators try to use it as a predictor of short term survival in the critically ill patients

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Critical Care

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Emad Zarief Kamel Said

Asyut, Asyut Governorate, 71111, Egypt

About this study

NLR will be used as predictor for short term survival and patients stay in ICU in 2 groups of patients . Investigators will use it in a group of Medical Critically ill patients as respiratory failure , neuromuscular disorders , renal impairment . the other group is the critically ill surgical patients , as patients with multiple trauma , post major surgery

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Critically ill trauma patients

Exclusion criteria

auto immune disease endocrine disease renal dysfunction hepatic dysfunction malignancy smoking

Treatment and study plan

Neutrophil Lymphocyte Ratio

Other

Neutrophil:lymphocyte ratio (NLR) is an emerging biomarker that is used to predict mortality and morbidity. The association of this biomarker with systemic illness and its usefulness in risk assessment of critically ill patients has not been fully elucidated.

Primary outcomes

short term survival

Time frame: one month

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Neutrophil Lymphocyte and Platelet Lymphocyte Ratios as Predictors of Outcome in Traumatic Critically Ill Patients

Important dates

Study start: 2015
Primary completion: 2016
Study completion: 2016
First posted: Apr 25, 2016
Registry last updated: Dec 16, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed